Minal K Patel1, Rosario Z Capeding2, Joyce U Ducusin3, Maricel de Quiroz Castro4, Luzviminda C Garcia5, Karen Hennessey6. 1. Global Immunization Division, Centers for Disease Control and Prevention, 1600 Clifton Road, MS A-04, Atlanta, GA, United States. Electronic address: hgo9@cdc.gov. 2. Research Institute of Tropical Medicine, Department of Health Compound, Filinvest Corporate City, Alabang, Muntinlupa City 1781, Philippines. Electronic address: lerosecap@yahoo.com.ph. 3. Expanded Programme on Immunization, Department of Health, San Lazaro Compound, Tayuman, Sta. Cruz, Manila, Philippines. Electronic address: juducusin@yahoo.com. 4. Expanded Programme on Immunization, World Health Organization, Office of the WHO Representative in the Philippines, Department of Health, San Lazaro Compound, Building 3 G/F, Tayuman, Sta. Cruz, Manila, Philippines. Electronic address: castroma@wpro.who.int. 5. Expanded Programme on Immunization, Department of Health, San Lazaro Compound, Tayuman, Sta. Cruz, Manila, Philippines. Electronic address: luzcgarcia@gmail.com. 6. Expanded Programme on Immunization, Western Pacific Regional Office, World Health Organization, P.O. Box 2932, UN Avenue, Manila 1000, Philippines. Electronic address: hennesseyk@wpro.who.int.
Abstract
BACKGROUND: Hepatitis B vaccination in the Philippines was introduced in 1992 to reduce the high burden of chronic hepatitis B virus (HBV) infection in the population; in 2007, a birth dose (HepB-BD) was introduced to decrease perinatal HBV transmission. Timely HepB-BD coverage, defined as doses given within 24h of birth, was 40% nationally in 2011. A first step in improving timely HepB-BD coverage is to ensure that all newborns born in health facilities are vaccinated. METHODS: In order to assess ways of improving the Philippines' HepB-BD program, we evaluated knowledge, attitudes, and practices surrounding HepB-BD administration in health facilities. Teams visited selected government clinics, government hospitals, and private hospitals in regions with low reported HepB-BD coverage and interviewed immunization and maternity staff. HepB-BD coverage was calculated in each facility for a 3-month period in 2011. RESULTS: Of the 142 health facilities visited, 12 (8%) did not provide HepB-BD; seven were private hospitals and five were government hospitals. Median timely HepB-BD coverage was 90% (IQR 80%-100%) among government clinics, 87% (IQR 50%-97%) among government hospitals, and 50% (IQR 0%-90%) among private hospitals (p=0.02). The private hospitals were least likely to receive supervision (53% vs. 6%-31%, p=0.0005) and to report vaccination data to the national Expanded Programme on Immunization (36% vs. 96%-100%, p<0.0001). CONCLUSIONS: Private sector hospitals in the Philippines, which deliver 18% of newborns, had the lowest timely HepB-BD coverage. Multiple avenues exist to engage the private sector in hepatitis B prevention including through existing laws, newborn health initiatives, hospital accreditation processes, and raising awareness of the government's free vaccine program.
BACKGROUND: Hepatitis B vaccination in the Philippines was introduced in 1992 to reduce the high burden of chronic hepatitis B virus (HBV) infection in the population; in 2007, a birth dose (HepB-BD) was introduced to decrease perinatal HBV transmission. Timely HepB-BD coverage, defined as doses given within 24h of birth, was 40% nationally in 2011. A first step in improving timely HepB-BD coverage is to ensure that all newborns born in health facilities are vaccinated. METHODS: In order to assess ways of improving the Philippines' HepB-BD program, we evaluated knowledge, attitudes, and practices surrounding HepB-BD administration in health facilities. Teams visited selected government clinics, government hospitals, and private hospitals in regions with low reported HepB-BD coverage and interviewed immunization and maternity staff. HepB-BD coverage was calculated in each facility for a 3-month period in 2011. RESULTS: Of the 142 health facilities visited, 12 (8%) did not provide HepB-BD; seven were private hospitals and five were government hospitals. Median timely HepB-BD coverage was 90% (IQR 80%-100%) among government clinics, 87% (IQR 50%-97%) among government hospitals, and 50% (IQR 0%-90%) among private hospitals (p=0.02). The private hospitals were least likely to receive supervision (53% vs. 6%-31%, p=0.0005) and to report vaccination data to the national Expanded Programme on Immunization (36% vs. 96%-100%, p<0.0001). CONCLUSIONS: Private sector hospitals in the Philippines, which deliver 18% of newborns, had the lowest timely HepB-BD coverage. Multiple avenues exist to engage the private sector in hepatitis B prevention including through existing laws, newborn health initiatives, hospital accreditation processes, and raising awareness of the government's free vaccine program.
Authors: Tilman A Ruff; Lulu Bravo; Salvacion R Gatchalian; Hans L Bock Journal: Southeast Asian J Trop Med Public Health Date: 2009-09 Impact factor: 0.267
Authors: Susan T Goldstein; Fangjun Zhou; Stephen C Hadler; Beth P Bell; Eric E Mast; Harold S Margolis Journal: Int J Epidemiol Date: 2005-10-25 Impact factor: 7.196
Authors: Anna Lena Lopez; Michelle Ylade; Jedas Veronica Daag; Amado O Tandoc; Joseph Bonifacio; Patrick G Sylim; Ava Kristy Sy; Rex Centeno; Vito Roque; Maria Joyce Ducusin Journal: Hum Vaccin Immunother Date: 2018-06-28 Impact factor: 3.452